348 related articles for article (PubMed ID: 18991198)
21. Wilson's disease: clinical management and therapy.
Brewer GJ; Askari FK
J Hepatol; 2005; 42 Suppl(1):S13-21. PubMed ID: 15777568
[No Abstract] [Full Text] [Related]
22. Cold comfort pharm.
Will RG
Pract Neurol; 2008 Feb; 8(1):60-1. PubMed ID: 18230710
[TBL] [Abstract][Full Text] [Related]
23. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
24. Cystic white-matter changes in childhood Wilson's disease.
Sankhyan N; Sharma S; Kalra V; Garg A; Balkrishnan P
Pediatr Neurol; 2008 Oct; 39(4):281-2. PubMed ID: 18805369
[TBL] [Abstract][Full Text] [Related]
25. [Current principles of Wilson's disease--diagnosis and treatment].
Najda J; Stella-Hołowiecka B; Machalski M; Woszczyk D; Mykała-Cieśla J
Wiad Lek; 2002; 55(9-10):600-7. PubMed ID: 12607416
[TBL] [Abstract][Full Text] [Related]
26. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
[TBL] [Abstract][Full Text] [Related]
27. Two male patients with Wilson's disease treated using trientine and iron reduction therapy.
Hayashi H; Ueno T; Yano M; Okada T; Mabuchi H
J Gastroenterol Hepatol; 2005 Oct; 20(10):1627-8. PubMed ID: 16174091
[No Abstract] [Full Text] [Related]
28. Wilson's disease with myoclonus and white matter lesions.
Barbosa ER; Silveira-Moriyama L; Machado AC; Bacheschi LA; Rosemberg S; Scaff M
Parkinsonism Relat Disord; 2007 Apr; 13(3):185-8. PubMed ID: 16740400
[TBL] [Abstract][Full Text] [Related]
29. Central pontine signal changes in Wilson's disease: distinct MRI morphology and sequential changes with de-coppering therapy.
Sinha S; Taly AB; Ravishankar S; Prashanth LK; Vasudev MK
J Neuroimaging; 2007 Oct; 17(4):286-91. PubMed ID: 17894614
[TBL] [Abstract][Full Text] [Related]
30. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
[TBL] [Abstract][Full Text] [Related]
31. [Biochemical bases and therapeutic possibilities of K. Wilson's hepatolenticular degeneration].
Grau-Veciana JM; Barraquer-Bordas L
Arch Neurobiol (Madr); 1967; 30(3):251-74. PubMed ID: 4970136
[No Abstract] [Full Text] [Related]
32. Stereotypies in Wilson's disease.
Yorio AA; Mesri JC; Pagano MA; Lera G
Mov Disord; 1997 Jul; 12(4):614-6. PubMed ID: 9251089
[No Abstract] [Full Text] [Related]
33. Idiopathic thrombocytopenia associated with Wilson's disease.
Donfrid M; Jankovic G; Strahinja R; Colovic R; Begic-Janeva A; Colovic M
Hepatogastroenterology; 1998; 45(23):1774-6. PubMed ID: 9840146
[TBL] [Abstract][Full Text] [Related]
34. [Maintenance treatment of Wilson's disease with oral zinc. Apropos of a child treated for 4 years].
Alexiou D; Hatzis T; Koutselinis A
Arch Fr Pediatr; 1985; 42(6):447-9. PubMed ID: 4051676
[TBL] [Abstract][Full Text] [Related]
35. Chelation therapy in Wilson's disease: from D-penicillamine to the design of selective bioinspired intracellular Cu(I) chelators.
Delangle P; Mintz E
Dalton Trans; 2012 Jun; 41(21):6359-70. PubMed ID: 22327203
[TBL] [Abstract][Full Text] [Related]
36. Cranial MR imaging in Wilson's disease.
King AD; Walshe JM; Kendall BE; Chinn RJ; Paley MN; Wilkinson ID; Halligan S; Hall-Craggs MA
AJR Am J Roentgenol; 1996 Dec; 167(6):1579-84. PubMed ID: 8956601
[TBL] [Abstract][Full Text] [Related]
37. Chelation treatment of neurological Wilson's disease.
Walshe JM; Yealland M
Q J Med; 1993 Mar; 86(3):197-204. PubMed ID: 8369040
[TBL] [Abstract][Full Text] [Related]
38. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
[TBL] [Abstract][Full Text] [Related]
39. Anticopper efficacy of captopril and sodium dimercaptosulphonate in patients with Wilson's disease.
Wang XP; Yang RM; Ren MS; Sun BM
Funct Neurol; 2003; 18(3):149-53. PubMed ID: 14703896
[TBL] [Abstract][Full Text] [Related]
40. Wilson's disease with depression and parkinsonism.
Chan KH; Cheung RT; Au-Yeung KM; Mak W; Cheng TS; Ho SL
J Clin Neurosci; 2005 Apr; 12(3):303-5. PubMed ID: 15851088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
